| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 84916 |
Boc-PEG4-Val-Ala-PAB-PNP |
132 |
zyl |
2024-12-18 |
| 84917 |
111 In-奥曲肽(Octreo Scan) |
663 |
h |
2024-12-18 |
| 84918 |
POSS-DOTA 大环配体DOTA偶联七异丁基-氨丙基六面体倍半硅氧烷POSS |
164 |
h |
2024-12-18 |
| 84919 |
cas:164332-88-1,N-Boc-PEG1-bromide, [2-(2-溴乙氧基)乙基]氨基甲酸叔丁酯 |
133 |
kx |
2024-12-18 |
| 84920 |
DOTA-Substance P DOTA-SP |
184 |
h |
2024-12-18 |
| 84921 |
Mal-amido-PEG8-val-gly-PAB-OH CAS:2353409-52-4 |
144 |
zyl |
2024-12-18 |
| 84922 |
FITC-Gly-Gly-Gly-CBT |
138 |
h |
2024-12-18 |
| 84923 |
FITC-Gly-Gly-Gly-CBT |
195 |
h |
2024-12-18 |
| 84924 |
FAM-amido hexamethylene carbamate-PAB-Cit-Val-Alkyne,荧光素类染料的一种 |
204 |
WYQ |
2024-12-18 |
| 84925 |
cas:98604-88-7,Bis-SS-C3-NHS ester, ADC试剂 |
163 |
kx |
2024-12-18 |
| 84926 |
DOTA-钆特酸葡甲胺 Gd-DOTA |
252 |
h |
2024-12-18 |
| 84927 |
MAL-tri-EG-OPFP的介绍 |
187 |
zyl |
2024-12-18 |
| 84928 |
NH2-PEG-NH2 氨基-聚乙二醇-氨基 |
190 |
h |
2024-12-18 |
| 84929 |
cas:1884578-00-0,Boc-Val-Ala-PAB-PNP |
149 |
kx |
2024-12-18 |
| 84930 |
CAS号为1613321-01-9的6-Azidohexanoyl-Val-Cit-PAB |
152 |
WYQ |
2024-12-18 |
| 84931 |
聚乙二醇PEG-DOTA修饰超支化聚乙烯亚胺 PEI-PEG-DOTA |
179 |
h |
2024-12-18 |
| 84932 |
DOTA修饰奥曲肽 DOTA-octreotide |
158 |
h |
2024-12-18 |
| 84933 |
CAS号为644981-35-1的Val-Cit-PAB-MMAE |
137 |
WYQ |
2024-12-18 |
| 84934 |
DOTA-KEK-(GX1)2 DOTA修饰GX1的二聚体 |
185 |
h |
2024-12-18 |
| 84935 |
cas:1639939-40-4,MC-Val-Ala-PAB-PNP, ADC试剂 |
144 |
kx |
2024-12-18 |
| 84936 |
endo BCN-PEG3-Val-Cit,CAS号:1263166-91-1 |
158 |
WYQ |
2024-12-18 |
| 84937 |
Azide-DOTA-Eu 叠氮-DOTA-Eu |
136 |
h |
2024-12-18 |
| 84938 |
CAS号:2353409-45-5 endo BCN-PEG3-VC-PFP Ester |
133 |
WYQ |
2024-12-18 |
| 84939 |
Fe3O4@TCPP-DOTA-Ho3+ 钬固载四氧化三铁磁性纳米颗粒偶联TCPP功能化DOTA大环配体 |
144 |
h |
2024-12-18 |
| 84940 |
cas:1360436-95-8,H-DL-Phe(4-Ac)-OH·HCl, 3-(4-乙酰基苯基)-2-氨基丙酸盐酸盐 |
142 |
kx |
2024-12-18 |
| 84941 |
CAS号:2226472-28-0 DBCO-PEG4-Val-Cit-PAB-PNP |
146 |
WYQ |
2024-12-18 |
| 84942 |
PPI-DOTA 第四代聚丙烯亚胺树状大分子PPI修饰DOTA螯合剂 |
190 |
h |
2024-12-18 |
| 84943 |
Fmoc-NH-PEG9-CH2CH2COOH CAS:1191064-81-9-ADC分子 |
217 |
zyl |
2024-12-18 |
| 84944 |
四巯基功能化的聚集诱导发光分子(TPE-4SH) |
203 |
h |
2024-12-18 |
| 84945 |
cas:1807512-47-5,Mal-PEG2-PFP ester,马来酰亚胺-二聚乙二醇-五氟苯酚酯 |
137 |
kx |
2024-12-18 |
| 84946 |
单抗MN14-DOTA 大环配体DOTA修饰单抗MN14 |
150 |
h |
2024-12-18 |
| 84947 |
Oleoyl-Gly-Lys-N-(m-PEG11)烷基链 |
147 |
zyl |
2024-12-18 |
| 84948 |
DOTA-Gd-Au PENPs mPEG修饰钆螯合剂包裹金纳米粒 |
144 |
h |
2024-12-18 |
| 84949 |
Fmoc-Gly3-Val-Cit-PAB-PNP烷基链定制 |
156 |
zyl |
2024-12-18 |
| 84950 |
cas:1268488-70-5,Bis-PEG9-acid,4,7,10,13,16,19,22,25,28-九氧杂三十一烷-1,31-二酸 |
113 |
kx |
2024-12-18 |
| 84951 |
DOTA-SSTa DOTA修饰SSTa抑制剂 |
202 |
h |
2024-12-18 |
| 84952 |
CAS号为1350456-56-2的Fmoc-Val-Cit-PAB-MMAE |
130 |
WYQ |
2024-12-18 |
| 84953 |
CAS号为2353409-69-3的Mal-PEG8-Val-Cit-PAB-MMAE |
172 |
WYQ |
2024-12-18 |
| 84954 |
cy5.5-QS cy5.5荧光标记VEGF125-136小肽QS |
127 |
h |
2024-12-18 |
| 84955 |
THP-SS-PEG1-Boc CAS:1807503-88-3 |
131 |
zyl |
2024-12-18 |
| 84956 |
cas:132178-37-1,Propargyl-C1-NHS ester,2, 5-二氧代吡咯烷-1-基 戊-4-炔酸酯 |
119 |
kx |
2024-12-18 |
| 84957 |
CAS号为646502-53-6的MC-Val-Cit-PAB-MMAE |
163 |
WYQ |
2024-12-18 |
| 84958 |
DOTA-ECL1i 7-氨基酸CCR2结合肽[外环1变型(ECL1i)]偶联DOTA大环配体 |
207 |
h |
2024-12-18 |
| 84959 |
MC-EVCit-PAB-MMAE(CAS号:2873452-49-2) |
121 |
WYQ |
2024-12-18 |
| 84960 |
TPP-Lys(Acp-DOTA-Gd)-COOH Gd-DOTA-TPP 卟啉修饰DOTA钆配合物 |
148 |
h |
2024-12-18 |